KKR & Co. Inc. (NYSE:KKR – Get Free Report) announced a quarterly dividend on Thursday, October 24th, NASDAQ reports. Stockholders of record on Monday, November 4th will be paid a dividend of 0.175 per share by the asset manager on Tuesday, November 19th. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date is Monday, November 4th.
KKR & Co. Inc. has increased its dividend by an average of 7.0% annually over the last three years. KKR & Co. Inc. has a dividend payout ratio of 11.6% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect KKR & Co. Inc. to earn $5.27 per share next year, which means the company should continue to be able to cover its $0.70 annual dividend with an expected future payout ratio of 13.3%.
KKR & Co. Inc. Price Performance
Shares of NYSE KKR opened at $137.58 on Friday. The firm has a market cap of $122.09 billion, a P/E ratio of 41.82, a price-to-earnings-growth ratio of 1.16 and a beta of 1.62. The business’s 50 day moving average is $130.44 and its 200-day moving average is $115.41. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86. KKR & Co. Inc. has a 1-year low of $57.49 and a 1-year high of $147.15.
Insider Buying and Selling
In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the sale, the insider now owns 25,260,971 shares in the company, valued at $650,470,003.25. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of KKR & Co. Inc. stock in a transaction dated Wednesday, September 11th. The shares were bought at an average cost of $11.13 per share, for a total transaction of $129,330,577.74. Following the completion of the acquisition, the insider now owns 92,959,984 shares in the company, valued at approximately $1,034,644,621.92. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the transaction, the insider now owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 39.34% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
KKR has been the subject of a number of recent research reports. Hsbc Global Res raised shares of KKR & Co. Inc. to a “strong-buy” rating in a report on Wednesday, September 18th. Keefe, Bruyette & Woods reiterated an “outperform” rating and issued a $144.00 price target (up from $125.00) on shares of KKR & Co. Inc. in a research note on Thursday, August 1st. Oppenheimer raised their price objective on KKR & Co. Inc. from $128.00 to $148.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 16th. The Goldman Sachs Group upped their target price on KKR & Co. Inc. from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Friday, October 25th. Finally, TD Cowen raised their price target on KKR & Co. Inc. from $166.00 to $184.00 and gave the stock a “buy” rating in a research report on Friday, October 25th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $151.64.
Check Out Our Latest Stock Report on KKR & Co. Inc.
About KKR & Co. Inc.
KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.
Read More
- Five stocks we like better than KKR & Co. Inc.
- Trading Stocks: RSI and Why it’s Useful
- Battle of the Retailers: Who Comes Out on Top?
- What is a Dividend King?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Russell 2000 Index, How Investors Use it For Profitable Trading
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.